LYVISPAH
LIVE

Serial Number

90869741

Owner

AMNEAL PHARMACEUTICALS LLC

Attorney

Jeffrey H. Handelsman

First Use Date

Jun 1, 2022

Filing Date

Aug 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LYVISPAH Trademark

Serial Number: 90869741 • Registration: 7013712

LYVISPAH is a trademark filed by AMNEAL PHARMACEUTICALS LLC on August 6, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AMNEAL PHARMACEUTICALS LLC (112 trademarks)

Third Floor
Bridgewater, NJ 08807

Entity Type: 16

Saol Therapeutics Research Limited (6 trademarks)

Ground Floor, 9 Windsor Place
Dublin 2 D02 YF30 , IE

Entity Type: 99

Trademark Details

Filing Date

August 6, 2021

Registration Date

March 28, 2023

First Use Anywhere

June 1, 2022

First Use in Commerce

June 1, 2022

Published for Opposition

June 7, 2022

Goods & Services

Pharmaceutical preparation for the treatment of spasticity

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 2, 2025 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 28, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 23, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 22, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 21, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 21, 2023 AITU
USE AMENDMENT FILED
Jan 27, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 27, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 2, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2022 CNSA
ASSIGNED TO EXAMINER
May 5, 2022 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 9, 2022 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2021 NWOS
NEW APPLICATION ENTERED
Aug 10, 2021 NWAP